SCHEMBL6408307

SCHEMBL6408307

O=c1[nH]c2cc(CO)ccc2c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 15/20 0.60
KDM4E B2RXH2 2/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
TNKS O95271 1/20 0.56
LMNA P02545 1/20 0.56
CYP1A2 P05177 1/20 0.56
GPR3 P46089 1/20 0.56
BLM P54132 1/20 0.56
PMP22 Q01453 1/20 0.56
KMT2A Q03164 1/20 0.56
PARP15 Q460N3 1/20 0.56
HSD17B10 Q99714 1/20 0.56
TNKS2 Q9H2K2 1/20 0.56
KIF11 P52732 1/20 0.47
CSNK2A1 P68400 1/20 0.47
CASP7 P55210 1/20 0.46
CASP6 P55212 1/20 0.46
CASP8 Q14790 1/20 0.46
MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30273140 0.81 PARP1 (0.61) PARP1KDM4EALDH1A1KIF11MAOA
SCHEMBL30577704 0.78 PARP1 (0.57) PARP1KDM4EALDH1A1LMNACYP1A2
SCHEMBL26775706 0.77 PARP1 (0.63) PARP1KDM4EALDH1A1MEN1TNKS
SCHEMBL30577697 0.76 PARP1 (0.52) PARP1KDM4EALDH1A1LMNACYP1A2
SCHEMBL25093575 0.75 PARP1 (0.55) PARP1MAOADYRK1A
SCHEMBL30577701 0.75 PARP1 (1.00) PARP1KDM4EPARP15TNKS2CSNK2A1
SCHEMBL1450878 0.75 PARP1 (1.00) PARP1KDM4EPARP15TNKS2CSNK2A1
SCHEMBL30018776 0.75 PARP1 (0.55) PARP1MAOADYRK1A
SCHEMBL6406734 0.75 PARP1 (0.77) PARP1KDM4EALDH1A1HSD17B10KCNH2
SCHEMBL9273141 0.74 HPGD (0.63) PARP1KDM4EALDH1A1MEN1TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171101-A1 Phenanthridinones as parp inhibitors FUJISAWA PHARMACEUTICAL CO. LTD. (JP) 2005-08-04 US disclosed
EP-1487800-A1 PHENANTHRIDINONES AS PARP INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed
WO-2003080581-A1 PHENANTHRIDINONES AS PARP INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171101-A1 Phenanthridinones as parp inhibitors PARP1, PARP11, PARP2 PARP1 1/4885KDM4E 721/4885ALDH1A1 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.